Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin.

Date publication

mai 2018

Journal

The British journal of surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr AVEROUS Gerlinde , Pr MARCHAL Frédéric , Pr BRIGAND Cécile

Tous les auteurs :
Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29412465

Résumé

The prognostic value of the primary neoplasm responsible for pseudomyxoma peritonei (PMP) remains poorly studied. The aim of this study was to determine the prognosis for patients with extra-appendicular PMP (EA-PMP) treated optimally with complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Mots clés

Appendiceal Neoplasms, diagnosis, Cytoreduction Surgical Procedures, methods, Disease-Free Survival, Female, Humans, Hyperthermia, Induced, methods, Male, Middle Aged, Peritoneal Neoplasms, diagnosis, Prognosis, Pseudomyxoma Peritonei, diagnosis, Retrospective Studies, Survival Analysis

Référence

Br J Surg. 2018 May;105(6):668-676